-
10/23/24 Health Advisory: Presumed positive human cases of avian influenza in Washington.
Washington State Department of Health is investigating presumed positive human cases of avian influenza in Washington. Healthcare providers should consider avian influenza in patients who present with acute respiratory illness, isolated conjunctivitis, or influenza-like illness (ILI). Assess patients for exposure to animals––especially poultry, cattle, and wildlife, or to people suspected or known to be infected. Current…
-
11/08/22 Health Advisory: Increased Respiratory Virus Activity
Advisory or Update, Health Advisory, Immunizations, Infection Control, News and Alerts, Provider Resources, SchoolsMultiple viruses are causing increased respiratory illness, especially among children, straining healthcare systems. Transmission of respiratory illnesses is increased in our communities. Schools report much higher absenteeism than normal for this time of year. Our hospital emergency departments are seeing many patients. This increase in illness early in respiratory illness season highlights the importance of…
-
10/27/22 Health Advisory: 2022–2023 Influenza Season Surveillance, Testing & Treatment
Advisory or Update, Health Advisory, Immunizations, Influenza, Influenza Update, Notifiable Conditions, Provider ResourcesRequested actions Vaccine This season’s updates in Centers for Disease Control and Prevention’s (CDC’s) Prevention and Control of Influenza (MMWR Vol. 71/No. 1): Surveillance Seasonal influenza surveillance starts in October and continues through April. We expect SARS-CoV-2 and influenza viruses will circulate simultaneously. To aid testing and treatment decisions, stay aware of local influenza and…
-
10/19/22 Health Advisory: Updated bivalent COVID-19 boosters available to children 5 years or older
Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesCenters for Disease Control and Prevention (CDC), Food and Drug Administration (FDA) and Western States Scientific Safety Review Workgroup approved an age expansion for updated bivalent COVID-19 vaccine booster doses. The expansion allows children: 5–11 years old to get 1 booster dose of Pfizer pediatric updated bivalent COVID-19 vaccine. 6–17 years old to get 1…
-
10/03/22 Health Advisory: Severe cases of monkeypox among people with immune compromise
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, monkeypox, Notifiable Conditions, Provider ResourcesSince May 2022, the United States has seen more than 25,000 cases of monkeypox virus (MPV). Most cases are mild to moderate, but some people are at higher risk of severe illness: Under 8 years old. Immune compromise. Atopic dermatitis or eczema. Pregnant. Unsuppressed or uncontrolled human immunodeficiency virus (HIV). Of those currently diagnosed with MPV…
-
09/09/22 Health Advisory: COVID-19 and Monkeypox Update for Providers
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Immunizations, monkeypox, Notifiable Conditions, Provider ResourcesCOVID-19 Monkeypox Monkeypox virus (MPV) is an ongoing health emergency. Pierce County has 40 reported cases. The United States has over 21,000 reported cases. See our provider resources monkeypox page for prevention, testing and treatment guidance. Monkeypox is a notifiable condition. Call to report suspected or confirmed cases within 24 hours. Jynneos vaccine We have a limited…
-
09/02/22 Health Advisory: Bivalent Vaccine Booster for COVID-19
Advisory or Update, COVID-19, Health Advisory, Immunizations, Notifiable Conditions, Provider ResourcesRequested actions Be aware: Moderna and Pfizer created bivalent formulations of their mRNA COVID-19 vaccines. The bivalent vaccines target the original strain of SARS-CoV-2 and Omicron subvariants BA.4 and BA.5. United States Food and Drug Administration (FDA) granted emergency use authorization (EUA) to the bivalent vaccines for use as a single booster dose. People can get…
-
08/25/22 Health Advisory: Monkeypox and COVID-19 Update for Providers
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Infection Control, monkeypox, News and Alerts, Notifiable Conditions, Provider ResourcesRequested actions Suspect monkeypox virus (MPV) infection in any patient who presents with 1 or more lesions that suggest MPV, regardless of the patient’s age, social history, gender or sexual identity. Several commercial labs, as well as Washington State Public Health Labs (PHL), now test for MPV. PHL updated its MPV specimen collection guidance: Preferred…
-
07/28/22 Health Advisory: Novavax Available to Order
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Notifiable Conditions, Provider ResourcesRequested actions Be aware, Novavax COVID-19 vaccine is now available to order. Food and Drug Administration (FDA) granted it emergency use authorization (EUA) and Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup approved. EUA covers a 2-dose primary series for people 18 years or older, including those with immune compromise. Booster…
-
07/26/22 Health Advisory: Monkeypox Update
We continue to monitor the monkeypox outbreak in Washington and the United States. Report possible monkeypox cases immediately upon suspicion, as Washington State Department of Health (DOH) requires. Call . We will help you complete an intake form and review exposure guidelines to evaluate close contacts. Monkeypox is rare and not often seen in the United States. It can cause a rash…
-
06/24/22 Health Advisory: Updated Monkeypox Guidance
Requested actions Immediately report suspected monkeypox cases to Tacoma-Pierce County Health Department. Call (253) 649‑1412. Consider submitting a suspect monkeypox intake form to help us determine whether to test for monkeypox. Be aware, recent confirmed cases of monkeypox in the United States differ from the classic monkeypox presentation of previous outbreaks. To date, all United States…
-
06/22/22 Health Advisory: COVID-19 Vaccine for Children as Young as 6 Months
Communicable Disease and Immunization Update, Health Advisory, Immunizations, News and Alerts, Notifiable Conditions, Provider ResourcesBe aware, Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup concluded COVID-19 vaccines are safe and effective for children as young as 6 months. Available to children 6 months to 4 years old: Pfizer COVID-19 vaccine, in a 3-dose primary series. Be sure to review dosage and vial labeling…
-
06/08/22 Health Advisory: Routine childhood immunization rates down
Requested actions Bring your child and adolescent patients’ vaccinations up to date at every opportunity. Contact families who missed well-child visits or childhood vaccinations and ask them to come in for an appointment. Explain to families why it’s important to keep children’s and adolescents’ vaccinations up to date. Review Centers for Disease Control and Prevention’s…